Por: ABC News Business October 31, 2023
Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue. Sales of the drugmaker's COVID treatment Paxlovid and the vaccine Comirnaty slid 97% and 70%, respectively, as Pfizer, like its competitors, switched to selling on the commercial market instead of to governments. Both the company and analysts who follow it expected revenue from those key products to tumble this year before... + full article
Fox Business USA Business November 01, 2023
Pfizer CEO Albert Bourla discusses the pharma company's next big drug after its COVID vaccine on 'The Claman Countdown.' Pfizer on Tuesday reported its first quarterly loss since 2019 as demand for its . Sales of the company's coronavirus vaccine Comirnaty... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Tuesday, March 28 | Orlando Sentinel
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Newsweek USA Business February 06, 2023
Pfizer's involvement with the 2023 Grammy Awards sparked speculation online, with some viewers wondering how much input the pharmaceutical company had.The annual music ceremony was held at the Crypto.com Arena in Los Angeles, California on Sunday night, with Beyoncé... + más
Here's how to watch the 2023 Grammys on iPhone, iPad, Apple TV, and more | 9to5Mac
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. | MarketWatch
MarketWatch USA Business February 04, 2023
Pfizer stock, too, has fallen out of favor, along with other Covid plays. At $44, it’s down 15% this year, making it one of the worst performers in the index. And it’s 30% below its late 2021 peak, badly trailing the rest of the drug group. Now looks like the time to buy... + más
Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
Newsweek USA Business February 02, 2023
Pharmaceutical giant Pfizer has been accused of making an obscene profit from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year.The company's COVID products Comirnaty, an mRNA vaccine and... + más
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
About iurex | Privacy Policy | Disclaimer |